Safety and Efficacy of the Combination of Ibrutinib and Nivolumab in Patients with Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Autor: Younes, Anas, Brody, Joshua *, Carpio, Cecilia *, Lopez-Guillermo, Armando, Ben-Yehuda, Dina *, Ferhanoglu, A. Burhan, Nagler, Arnon, Ozcan, Muhit, Avivi, Irit *, Bosch Albareda, Francesc *, Caballero Barrigón, María Dolores *, Masood, Aisha *, Streit, Michael *, Alvarez, John *, Ceulemans, Rob *, Kharabi Masouleh, Behzad, Balasubramanian, Sriram, Schaffer, Michael *, Wang, Shean-Sheng *, Fourneau, Nele *, Jurczak, Wojciech
Zdroj: In Blood 8 December 2017 130 Supplement 1:833-833
Databáze: ScienceDirect